HOWL

Werewolf Therapeutics, Inc.

SEC CIK 1785530
$0.3810 −40.7% · 90 days
90-day buys
$0
0 open-market
90-day sells
$1.73M
41 open-market
Net insider flow
−$1.73M
Net selling
Filings shown
103
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at HOWL have sold a net $1.73M of stock (0 open-market buys vs 41 sells).

Largest recent trade: Ra Capital Management, L.p. sold $249.6K of HOWL, trimming their stake 6%.

Most active filer: Evnin Luke, with 59 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for HOWL, newest first
View on SEC EDGAR ↗
HOWL
Sell GADICKE ANSBERT · 10% Owner · Open-market sale · filed Nov 12, 2025 ΔOwn −1.0%

Gadicke Ansbert sold $63.6K of HOWL, trimming their stake 1%.

−$63.6K
55,810 sh @ $1
HOWL
Sell GADICKE ANSBERT · 10% Owner · Open-market sale · filed Nov 12, 2025 ΔOwn −0.8%

Gadicke Ansbert sold $57.3K of HOWL, trimming their stake 1%.

−$57.3K
48,570 sh @ $1
HOWL
Sell GADICKE ANSBERT · 10% Owner · Open-market sale · filed Nov 6, 2025 ΔOwn −0.9%

Gadicke Ansbert sold $65.9K of HOWL, trimming their stake 1%.

−$65.9K
54,452 sh @ $1
HOWL
Sell GADICKE ANSBERT · 10% Owner · Open-market sale · filed Nov 6, 2025 ΔOwn −0.8%

Gadicke Ansbert sold $58.5K of HOWL, trimming their stake 1%.

−$58.5K
47,950 sh @ $1
Advertisement
HOWL
Sell GADICKE ANSBERT · 10% Owner · Open-market sale · filed Nov 6, 2025 ΔOwn −2.3%

Gadicke Ansbert sold $171.4K of HOWL, trimming their stake 2%.

−$171.4K
140,488 sh @ $1
HOWL
Sell GADICKE ANSBERT · 10% Owner · Open-market sale · filed Nov 3, 2025 ΔOwn −1.5%

Gadicke Ansbert sold $121.3K of HOWL, trimming their stake 2%.

−$121.3K
94,063 sh @ $1
HOWL
Sell GADICKE ANSBERT · 10% Owner · Open-market sale · filed Nov 3, 2025 ΔOwn −1.3%

Gadicke Ansbert sold $124.3K of HOWL, trimming their stake 1%.

−$124.3K
86,936 sh @ $1
HOWL
Sell GADICKE ANSBERT · 10% Owner · Open-market sale · filed Oct 29, 2025 ΔOwn −2.0%

Gadicke Ansbert sold $208.1K of HOWL, trimming their stake 2%.

−$208.1K
134,240 sh @ $2
HOWL
Sell GADICKE ANSBERT · 10% Owner · Open-market sale · filed Oct 29, 2025 ΔOwn −1.0%

Gadicke Ansbert sold $113.3K of HOWL, trimming their stake 1%.

−$113.3K
69,068 sh @ $2
HOWL
Sell GADICKE ANSBERT · 10% Owner · Open-market sale · filed Oct 29, 2025 ΔOwn −1.1%

Gadicke Ansbert sold $125.1K of HOWL, trimming their stake 1%.

−$125.1K
72,709 sh @ $2
Advertisement

About HOWL insider activity

This page tracks every recent Form 4 filed for Werewolf Therapeutics, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is HOWL insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Werewolf Therapeutics, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.